P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT02242760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT02242760
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novan, Inc.
- Industry
- Enrollment
- 213 participants
Conditions and interventions
Conditions
Interventions
- SB204 2% Drug
- SB204 4% Drug
- Vehicle Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2014
- Primary completion
- May 31, 2015
- Completion
- Jul 31, 2015
- Last update posted
- May 30, 2023
2014 – 2015
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Qst acne site #1 | Hot Springs | Arkansas | 71913 | — |
| QST Site #118 | Encinitas | California | 92024 | — |
| QST Site #111 | San Diego | California | 92123 | — |
| QST Site #113 | San Diego | California | 92123 | — |
| QST Site #119 | Santa Monica | California | 90404 | — |
| QST Site #103 | Boca Raton | Florida | 33486 | — |
| QST Site # 110 | Pinellas Park | Florida | 33781 | — |
| QST Site # 116 | Newnan | Georgia | 302636 | — |
| QST Site #117 | Louisville | Kentucky | 40202 | — |
| QST Site #112 | Detroit | Michigan | 48202 | — |
| QST Site #120 | Warren | Michigan | 48088 | — |
| QST Site # 121 | Minneapolis | Minnesota | 55432 | — |
| QST Site #107 | New York | New York | 10155 | — |
| QST Site #108 | Rochester | New York | 14623 | — |
| QST Site #109 | Rochester | New York | 14625 | — |
| QST Site #104 | Stony Brook | New York | 11790 | — |
| QST Site # 102 | San Antonio | Texas | 78229 | — |
| QST Site #106 | Salt Lake City | Utah | 84117 | — |
| QST #105 | Lynchburg | Virginia | 24501 | — |
| QST Site #114 | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02242760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02242760 live on ClinicalTrials.gov.